These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1721 related items for PubMed ID: 18405244

  • 1. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [Abstract] [Full Text] [Related]

  • 2. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K.
    Ann Acad Med Stetin; 2008 Mar; 54(1):41-8. PubMed ID: 19127808
    [Abstract] [Full Text] [Related]

  • 3. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
    [Abstract] [Full Text] [Related]

  • 4. Frequency and risk factors for posttransplant diabetes mellitus in Iranian renal transplant patients.
    Ossareh S, Naseem S, Faraji MA, Bahrami Asl M, Yousefnejad A.
    Transplant Proc; 2009 Sep; 41(7):2814-6. PubMed ID: 19765443
    [Abstract] [Full Text] [Related]

  • 5. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D, Keitel E, Heineck I, Cardoso BD, Rodrigues AP, Michel K, Garcia VD.
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [Abstract] [Full Text] [Related]

  • 6. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM, Gich I, Bonfill X, Solà R, Guirado L, Facundo C, Sainz Z, Puig T, Silva I, Ballarín J.
    Transplant Proc; 2009 Mar; 41(6):2151-5. PubMed ID: 19715859
    [Abstract] [Full Text] [Related]

  • 7. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 8. Early hyperglycemia: a risk factor for posttransplant diabetes mellitus among renal transplant recipients.
    Maldonado F, Tapia G, Ardiles L.
    Transplant Proc; 2009 Oct; 41(6):2664-7. PubMed ID: 19715996
    [Abstract] [Full Text] [Related]

  • 9. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus.
    Sens YA, Silva VD, Malafronte P, Souza JF, Miorin LA, Jabur P.
    Transplant Proc; 2004 May; 36(4):886-8. PubMed ID: 15194304
    [Abstract] [Full Text] [Related]

  • 10. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR.
    CMAJ; 1992 Sep 01; 147(5):645-57. PubMed ID: 1521210
    [Abstract] [Full Text] [Related]

  • 11. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 01; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 12. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
    Weinrauch LA, D'Elia JA, Gleason RE, Shaffer D, Monaco AP.
    Clin Nephrol; 1995 Sep 01; 44(3):185-92. PubMed ID: 8556835
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant diabetes mellitus: incidence and risk factors.
    Mazali FC, Lalli CA, Alves-Filho G, Mazzali M.
    Transplant Proc; 2008 Apr 01; 40(3):764-6. PubMed ID: 18455010
    [Abstract] [Full Text] [Related]

  • 14. Kidney transplantation from living donors: comparison of results between related and unrelated donor transplants under new immunosuppressive protocols.
    Chkhotua AB, Klein T, Shabtai EL, Yussim A, Bar-Nathan N, Shaharabani E, Lustig S, Mor E.
    Isr Med Assoc J; 2003 Sep 01; 5(9):622-5. PubMed ID: 14509149
    [Abstract] [Full Text] [Related]

  • 15. Is age associated with the number or types of medications prescribed to renal transplant recipients?
    Chisholm MA, Melroy J, Johnson M, Mulloy LL, Spivey CA.
    J Am Geriatr Soc; 2007 Mar 01; 55(3):389-94. PubMed ID: 17341241
    [Abstract] [Full Text] [Related]

  • 16. Obesity and renal transplantation.
    Merion RM, Twork AM, Rosenberg L, Ham JM, Burtch GD, Turcotte JG, Rocher LL, Campbell DA.
    Surg Gynecol Obstet; 1991 May 01; 172(5):367-76. PubMed ID: 2028371
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May 01; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 18. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus.
    Schiel R, Heinrich S, Steiner T, Ott U, Stein G.
    Nephrol Dial Transplant; 2005 Mar 01; 20(3):611-7. PubMed ID: 15689368
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul 01; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 20. Outcome of kidney transplantation in type 1 and type 2 diabetic patients and recipients with posttransplant diabetes mellitus.
    Einollahi B, Jalalzadeh M, Taheri S, Nafar M, Simforoosh N.
    Urol J; 2008 Jul 01; 5(4):248-54. PubMed ID: 19101899
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 87.